Showing results (241-250 of 260) with videos related to
Sort By:
Pageof 26
Cancers|July 24, 2021
Preclinical In Vivo-Models to Investigate HIPEC; Current Methodologies and ChallengesRoxan F C P A Helderman, Daan R Löke, Pieter J Tanis, et al.Oncotarget|April 22, 2017
Enhancing synthetic lethality of PARP-inhibitor and cisplatin in BRCA-proficient tumour cells with hyperthermiaArlene L Oei, Caspar M van Leeuwen, Vidhula R Ahire, et al.Journal of Thermal Biology|July 12, 2023
Quantitative analysis of contribution of mild and moderate hyperthermia to thermal ablation and sensitization of irreversible electroporation of pancreatic cancer cellsP Agnass, H M Rodermond, E van Veldhuisen, et al.Sensors (Basel, Switzerland)|November 4, 2020
HyCHEED System for Maintaining Stable Temperature Control during Preclinical Irreversible Electroporation Experiments at Clinically Relevant Temperature and Pulse SettingsPierre Agnass, Hans M Rodermond, Remko Zweije, et al.Oncotarget|August 25, 2016
Sensitizing thermochemotherapy with a PARP1-inhibitorArlene L Oei, Lianne E M Vriend, Caspar M van Leeuwen, et al.Journal of Communication Disorders|July 14, 2019
"Spontaneous" late recovery from stuttering: Dimensions of reported techniques and causal attributionsKatrin Neumann, Harald A Euler, Rebekka Zens, et al.Journal of Cancer Survivorship : Research and Practice|June 15, 2014
The use of equivalent radiation dose in the evaluation of late effects after childhood cancer treatmentIrma W E M van Dijk, Rob M van Os, Jeroen B van de Kamer, et al.Cell Death and Differentiation|April 25, 2015
Synaptic dysfunction, memory deficits and hippocampal atrophy due to ablation of mitochondrial fission in adult forebrain neuronsB Oettinghaus, J M Schulz, L M Restelli, et al.DNA Repair|December 15, 2012
Inhibition of homologous recombination by hyperthermia shunts early double strand break repair to non-homologous end-joiningJudith W J Bergs, Przemek M Krawczyk, Tijana Borovski, et al.Vaccine|June 2, 1998
An inactivated gE-negative marker vaccine and an experimental gD-subunit vaccine reduce the incidence of bovine herpesvirus 1 infections in the fieldJ C Bosch, M C De Jong, P Franken, et al.Pageof 26